agilon health, inc. (AGL)
Pre-market:
| Previous close | 5.13 |
| Open | 5.03 |
| Bid | 5.31 x 3000 |
| Ask | 0.00 x 3000 |
| Day's range | 5.04 - 5.52 |
| 52-week range | 4.41 - 26.75 |
| Volume | |
| Avg. volume | 4,784,786 |
| Market cap | 2.261B |
| Beta (5Y monthly) | 0.50 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
agilon health Sets Date to Report First Quarter 2024 Financial Results
AUSTIN, Texas, April 16, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2024 after the market closes on Tuesday, May 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results.
- Business Wire
agilon health Reports Fourth Quarter 2023 Results
AUSTIN, Texas, February 27, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the fourth quarter and fiscal year ended December 31, 2023.
- PR Newswire
AGL Credit Management Has Three CLOs Named Finalists for DealCatalyst's 2024 Deals of the Year Awards
AGL Credit Management LP ("AGL"), an experienced investment manager focused on corporate credit strategies, today announced three of its CLOs have been shortlisted as finalists for Deals of the Year by DealCatalyst's annual U.S. CLO Awards.
